Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal — Lung Cancer Update

Listen in the Podli app 🎧

Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.

Featuring an interview with Prof Ticiana Leal, including the following topics:

Pathophysiology and clinical signs and symptoms (0:00)
Screening and/or diagnostic approaches (5:45)
Potential impact of available therapies for small cell lung cancer (SCLC) on paraneoplastic syndromes (7:36)
Key clinical trial data for amifampridine and practicalities of its administration (14:05)
Building awareness among patients, caregivers and the oncology community (22:37)
Role of pyridostigmine in managing Lambert-Eaton myasthenic syndrome (LEMS); potential integration of EMG (electromyography) into monitoring (25:35)
Case: A man in his early 70s who receives a diagnosis of limited-stage SCLC (LS-SCLC) with LEMS and undergoes treatment (27:41)
Case: A woman in her late 70s already diagnosed with LS-SCLC who is subsequently evaluated and treated for LEMS (37:55)
Current research and potential developments in the treatment of SCLC (48:32)